MedPath

SI Joint Stabilization in Long Fusion to the Pelvis

Not Applicable
Completed
Conditions
Scoliosis Lumbar Region
Sacroiliac Joint Disruption
Interventions
Device: iFuse 3-D in Bedrock Configuration
Procedure: Multilevel Lumbar Fusion surgery
Registration Number
NCT04062630
Lead Sponsor
SI-BONE, Inc.
Brief Summary

The purpose of this study is to compare outcomes of subjects undergoing multilevel lumbar fusion (MLF) surgery with and without the iFuse 3-D implants in the "bedrock" trajectory.

Detailed Description

This is a multicenter randomized controlled, postmarket clinical study to determine the differences between subjects undergoing standard MLF surgery with S2AI fixation in the pelvis vs the additional placement of iFuse 3-D in the bedrock configuration during MLF surgery. Subjects will be monitored for sacroiliac (SI) joint pain and at two years post surgery a CT scan will be taken to assess S2AI screw loosening or any other findings.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
213
Inclusion Criteria
  1. Age 21-75 at time of screening
  2. Patient scheduled for multilevel (>3 levels) spinal fusion surgery with planned fixation to the pelvis using S2AI screws
  3. Patient has signed study-specific informed consent form
  4. Patient has the necessary mental capacity to participate and is physically able to comply with study protocol requirements
Exclusion Criteria
  1. Indication for multilevel spine fusion surgery is any of the following:

    1. Congenital neuromuscular disease
    2. Prior pelvic fixation (i.e., patient already has S2AI or iliac bolts in place, current surgery indicated to revise this hardware)
    3. Grade IV spondylolisthesis
  2. Prior sacroiliac joint fusion/fixation on either side

  3. Presence of spinal cord stimulator

  4. Presence of severe hip pain that could impair functional and quality of life improvement from complex spine surgery

  5. Surgeon plans to use iliac screw for pelvic fixation

  6. Any known sacral or iliac pathology

  7. Any condition or anatomy that makes treatment with the iFuse Implant System infeasible

  8. Known metabolic bone disease

  9. Severe osteoporosis

  10. Known allergy to titanium or titanium alloys

  11. Use of medications known to have detrimental effects on bone quality and soft-tissue healing

  12. Neurologic condition that would interfere with postoperative physical therapy

  13. Current local or systemic infection that raises the risk of surgery

  14. Patient currently receiving or seeking short- or long-term worker's compensation and/or currently involved in injury litigation related to the SI joint or low back pain.

  15. Currently pregnant or planning pregnancy in the next 2 years

  16. Prisoner or a ward of the state.

  17. Known or suspected drug or alcohol abuse

  18. Uncontrolled psychiatric disease that could interfere with study participation

  19. Fibromyalgia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard Care + iFuse 3-DMultilevel Lumbar Fusion surgeryMultilevel Lumbar Fusion Surgery with additional placement of iFuse 3-D in a trajectory parallel to the S2AI screws
Standard careMultilevel Lumbar Fusion surgeryMultilevel Lumbar Fusion Surgery
Standard Care + iFuse 3-DiFuse 3-D in Bedrock ConfigurationMultilevel Lumbar Fusion Surgery with additional placement of iFuse 3-D in a trajectory parallel to the S2AI screws
Primary Outcome Measures
NameTimeMethod
Change from baseline in self-reported SI joint pain at 2 years2 years

Change from baseline in self-reported SI joint pain on a 0 (no pain) -10 (worst imaginable pain) visual analog scale

Incidence of SI Joint pain2 years

Proportion of subjects without SI joint pain at baseline who develop new onset SI joint pain by 2 years

Proportion with S2AI screw abnormality on CT scan2 years

Proportion of subjects with any of following: S2AI screw breakage, loosening or pullout OR rod breakage distal to S1 on 2-year CT scan as interpreted by an independent bone radiologist

Secondary Outcome Measures
NameTimeMethod
Proportion of subjects requiring revision, removal, reoperation or supplemental fixation2 years

Proportion of subjects requiring revision, removal, reoperation or supplemental fixation related to S2AI screws or iFuse-3D

Therapeutic injection or other non-medication based intervention2 years

Proportion of subjects requiring therapeutic injection or other non-medication based intervention to treat SI joint pain

Scoliosis Research Society 22r Patient Questionnaire2 years

Change from baseline in self reported Scoliosis Research Society 22r Patient Questionnaire (SRS-22R) score at 2 years

Change from baseline thoracic kyphosis at 2 years2 years

Change from baseline thoracic kyphosis on 2-year CT scan as interpreted by an independent bone radiologist

Change from baseline pelvic incidence at 2 years2 years

Change from baseline pelvic incidence on 2-year CT scan as interpreted by an independent bone radiologist

Oswestry Disability Index2 years

Change from baseline in self reported Oswestry Disability Index (ODI) score at 2 years

EuroQol Group Health Questionnaire2 years

Change from baseline in self reported EuroQol Group Health Questionnaire with Time Trade Off Utility Index (EQ-5D TTO index) score at 2 years

Ambulatory and Work Status2 years

Change from baseline in self reported ambulatory and work status at 2 years

Opioid Medication Use2 years

Change from baseline opioid medications used, i.e., the mean daily dose during 2 weeks prior to each visit

Proportion of S2AI screw breakage2 years

Proportion of S2AI screws with any breakage over the course of the study on CT scan as interpreted by an independent bone radiologist

Proportion of S2AI screw loosening2 years

Proportion of S2AI screws with any loosening over the course of the study on CT scan as interpreted by an independent bone radiologist

Proportion of abnormal bone reactions in the pelvis2 years

Proportion of abnormal bone reactions in the pelvis at either the iFuse-3D implant or S2AI screw on 2-year CT scan as interpreted by an independent bone radiologist

iFuse-3D implant fully seated2 years

Proportion of iFuse-3D implants placed fully seated (at least 20mm) into the sacrum on 2-year CT scan as interpreted by an independent bone radiologist

iFuse-3D implant position2 years

Proportion of iFuse-3D implants with malposition (distal end outside of ilium) on 2-year CT scan as interpreted by an independent bone radiologist

Change from baseline pelvic tilt at 2 years2 years

Change from baseline pelvic tilt on 2-year CT scan as interpreted by an independent bone radiologist

Trial Locations

Locations (31)

William Beaumont Hospital

🇺🇸

Royal Oak, Michigan, United States

Rush University Medical Center

🇺🇸

Chicago, Illinois, United States

Austin Spine

🇺🇸

Austin, Texas, United States

Texas Back Institute

🇺🇸

Plano, Texas, United States

Ortho Virginia Research Institute

🇺🇸

Richmond, Virginia, United States

Klinikum Magdeburg

🇩🇪

Magdeburg, Germany

Scripps Hospital

🇺🇸

La Jolla, California, United States

Keck School of Medicine of USC

🇺🇸

Los Angeles, California, United States

University of Virginia - Dept of Neurosurgery

🇺🇸

Charlottesville, Virginia, United States

Barrow Neurological Institute

🇺🇸

Phoenix, Arizona, United States

Royal National Orthopaedic Hospital

🇬🇧

Stanmore, United Kingdom

University of Minnesota

🇺🇸

Minneapolis, Minnesota, United States

Mayo Clinic

🇺🇸

Rochester, Minnesota, United States

University of Colorado Denver

🇺🇸

Aurora, Colorado, United States

University of Arkansas for Medical Sciences

🇺🇸

Little Rock, Arkansas, United States

University of California, San Diego

🇺🇸

La Jolla, California, United States

St Mary's Medical Center

🇺🇸

San Francisco, California, United States

Parkview Regional Medical Center

🇺🇸

Fort Wayne, Indiana, United States

Axis Spine Center

🇺🇸

Coeur d'Alene, Idaho, United States

University of Buffalo Neurosurgery

🇺🇸

Buffalo, New York, United States

Hospital for Special Surgery

🇺🇸

New York, New York, United States

OrthoCarolina Research Institute

🇺🇸

Charlotte, North Carolina, United States

Ohio State University

🇺🇸

Columbus, Ohio, United States

Tennessee Orthopaedics Alliance

🇺🇸

Nashville, Tennessee, United States

UVA Spine Center - Ortho

🇺🇸

Charlottesville, Virginia, United States

North Texas Neurosurgical and Spine Center

🇺🇸

Fort Worth, Texas, United States

Epworth HealthCare

🇦🇺

Richmond, Victoria, Australia

Ospedale Civile di Legnano- ASST Ovest Milanese

🇮🇹

Legnano, Milan, Italy

Virginia Mason

🇺🇸

Seattle, Washington, United States

Orlando Health Physician Neurosurgery Group

🇺🇸

Orlando, Florida, United States

University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath